UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.422

Sortiert nach

Phenytoin and phenobarbital inhibit human HERG potassium channels

Epilepsy research, 2003, Vol.55 (1), p.147-157

2003

Link zum Volltext

Verfügbarkeit prüfen

Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo

European journal of pharmacology, 2011-01, Vol.651 (1-3), p.26-32

2011

Link zum Volltext

Verfügbarkeit prüfen

The impact of aromatic ring count on compound developability – are too many aromatic rings a liability in drug design?

Drug discovery today, 2009-11, Vol.14 (21), p.1011-1020

2009

Link zum Volltext

Verfügbarkeit prüfen

A bifunctional sea anemone peptide with Kunitz type protease and potassium channel inhibiting properties

Biochemical pharmacology, 2011-07, Vol.82 (1), p.81-90

2011

Link zum Volltext

Verfügbarkeit prüfen

Chronic Stress Causes Amygdala Hyperexcitability in Rodents

Biological psychiatry (1969), 2010-06, Vol.67 (12), p.1128-1136

2010

Link zum Volltext

Verfügbarkeit prüfen

Suppression of KCNQ/M (Kv7) potassium channels in dorsal root ganglion neurons contributes to the development of bone cancer pain in a rat model

Pain (Amsterdam), 2013-03, Vol.154 (3), p.434-448

2013

Link zum Volltext

Verfügbarkeit prüfen

ATP-dependent potassium channel blockade strengthens microglial neuroprotection after hypoxia–ischemia in rats

Experimental neurology, 2012-05, Vol.235 (1), p.282-296

2012

Link zum Volltext

Verfügbarkeit prüfen

Toxin modulators and blockers of hERG K+ channels

Toxicon (Oxford), 2012-09, Vol.60 (4), p.492-501

2012

Link zum Volltext

Verfügbarkeit prüfen

A binary QSAR model for classification of hERG potassium channel blockers

Bioorganic & medicinal chemistry, 2008-04, Vol.16 (7), p.4107-4119

2008

Link zum Volltext

Verfügbarkeit prüfen

Predictive models for hERG potassium channel blockers

Bioorganic & medicinal chemistry letters, 2005-08, Vol.15 (15), p.3637-3642

2005

Link zum Volltext

Verfügbarkeit prüfen

Pyrrolidine amides of pyrazolodihydropyrimidines as potent and selective Kv1.5 blockers

Bioorganic & medicinal chemistry letters, 2010-02, Vol.20 (4), p.1436-1439

2010

Link zum Volltext

Verfügbarkeit prüfen

Hemin inhibits the large conductance potassium channel in brain mitochondria: A putative novel mechanism of neurodegeneration

Experimental neurology, 2014-07, Vol.257, p.70-75

2014

Link zum Volltext

Verfügbarkeit prüfen

Potassium channels and pain: present realities and future opportunities

European journal of pharmacology, 2004-10, Vol.500 (1), p.203-219

2004

Link zum Volltext

Verfügbarkeit prüfen

Allosteric modulators of the hERG K+ channel Radioligand binding assays reveal allosteric characteristics of dofetilide analogs

Toxicology and applied pharmacology, 2014, Vol.274 (1), p.78-86

2014

Link zum Volltext

Verfügbarkeit prüfen

Sulfonate chalcone as new class voltage-dependent K + channel blocker

Bioorganic & medicinal chemistry letters, 2008, Vol.18 (1), p.137-140

2008

Link zum Volltext

Verfügbarkeit prüfen

Anti-addiction drug ibogaine inhibits voltage-gated ionic currents: A study to assess the drug's cardiac ion channel profile

Toxicology and applied pharmacology, 2013-12, Vol.273 (2), p.259-268

2013

Link zum Volltext

Verfügbarkeit prüfen

Pharmacology of neuronal background potassium channels

Neuropharmacology, 2003, Vol.44 (1), p.1-7

Lesage, Florian

2003

Link zum Volltext

Verfügbarkeit prüfen

Kv1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of Kv1.3 is effective in the SCID mouse psoriasis – Xenograft model

Journal of autoimmunity, 2014-12, Vol.55, p.63-72

2014

Link zum Volltext

Verfügbarkeit prüfen

Gambierol, a toxin produced by the dinoflagellate Gambierdiscus toxicus, is a potent blocker of voltage-gated potassium channels

Toxicon (Oxford), 2008-05, Vol.51 (6), p.974-983

2008

Link zum Volltext

Verfügbarkeit prüfen

A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs

European journal of pharmacology, 2002-08, Vol.450 (1), p.37-41

2002

Link zum Volltext

Verfügbarkeit prüfen

Postconditioning in focal cerebral ischemia: Role of the mitochondrial ATP-dependent potassium channel

Brain research, 2011-02, Vol.1375, p.137-146

2011

Link zum Volltext

Verfügbarkeit prüfen

Two dyad-free Shaker-type K+ channel blockers from scorpion venom

Toxicon (Oxford), 2012-03, Vol.59 (3), p.402-407

2012

Link zum Volltext

Verfügbarkeit prüfen

BK channel openers inhibit ROS production of isolated rat brain mitochondria

Experimental neurology, 2008-08, Vol.212 (2), p.543-547

2008

Link zum Volltext

Verfügbarkeit prüfen

Targeting A-type K+ channels in primary sensory neurons for bone cancer pain in a rat model

Pain (Amsterdam), 2012-03, Vol.153 (3), p.562-574

2012

Link zum Volltext

Verfügbarkeit prüfen

Fluconazole inhibits hERG K + channel by direct block and disruption of protein trafficking

European journal of pharmacology, 2011-01, Vol.650 (1), p.138-144

2011

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.422

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieAmerican Journal Of Physiology: Cell Physiology

ThemaMedical Sciences

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.373)
Mit Volltextzugriff
(1.415)

Publikationsform

Artikel
(1.422)

Sprache

Englisch
(1.422)
Japanisch
(306)
Französisch
(1)

Erscheinungsjahr

n.n

Thema

Biological And Medical Sciences
(1.422)
Life Sciences & Biomedicine
(1.261)
Science & Technology
(1.261)
Animals
(1.123)
Pharmacology. Drug Treatments
(992)
Pharmacology & Pharmacy
(762)
Male
(659)
Rats
(638)
In Vitro Techniques
(367)
Humans
(349)
Neurosciences & Neurology
(342)
Dose-Response Relationship, Drug
(323)
Potassium Channel Blockers - Pharmacology
(307)
Neurosciences
(288)
Cardiovascular System
(278)
Female
(277)
Calcium Channel Blockers - Pharmacology
(273)
Neuropharmacology
(256)
Neurology
(240)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

European Journal Of Pharmacology
(476)
Brain Research
(91)
Bioorganic & Medicinal Chemistry Letters
(68)
Neuroscience
(58)
Toxicon
(53)
Epilepsy Research
(49)
Biochemical Pharmacology
(41)
General Pharmacology
(37)
Neuropharmacology
(33)
The Lancet
(33)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phenytoin and phenobarbital inhibit human HERG potassium channels

Anti-proliferative effect of Kv1.3 blockers in A549 human lung adenocarcinoma in vitro and in vivo

The impact of aromatic ring count on compound developability – are too many aromatic rings a liability in drug design?

A bifunctional sea anemone peptide with Kunitz type protease and potassium channel inhibiting properties

Chronic Stress Causes Amygdala Hyperexcitability in Rodents

Suppression of KCNQ/M (Kv7) potassium channels in dorsal root ganglion neurons contributes to the development of bone cancer pain in a rat model

ATP-dependent potassium channel blockade strengthens microglial neuroprotection after hypoxia–ischemia in rats

Toxin modulators and blockers of hERG K+ channels

A binary QSAR model for classification of hERG potassium channel blockers

Predictive models for hERG potassium channel blockers

Pyrrolidine amides of pyrazolodihydropyrimidines as potent and selective Kv1.5 blockers

Hemin inhibits the large conductance potassium channel in brain mitochondria: A putative novel mechanism of neurodegeneration

Potassium channels and pain: present realities and future opportunities

Allosteric modulators of the hERG K+ channel Radioligand binding assays reveal allosteric characteristics of dofetilide analogs

Sulfonate chalcone as new class voltage-dependent K + channel blocker

Anti-addiction drug ibogaine inhibits voltage-gated ionic currents: A study to assess the drug's cardiac ion channel profile

Pharmacology of neuronal background potassium channels

Kv1.3 in psoriatic disease: PAP-1, a small molecule inhibitor of Kv1.3 is effective in the SCID mouse psoriasis – Xenograft model

Gambierol, a toxin produced by the dinoflagellate Gambierdiscus toxicus, is a potent blocker of voltage-gated potassium channels

A comparison of the receptor binding and HERG channel affinities for a series of antipsychotic drugs

Postconditioning in focal cerebral ischemia: Role of the mitochondrial ATP-dependent potassium channel

Two dyad-free Shaker-type K+ channel blockers from scorpion venom

BK channel openers inhibit ROS production of isolated rat brain mitochondria

Targeting A-type K+ channels in primary sensory neurons for bone cancer pain in a rat model

Fluconazole inhibits hERG K + channel by direct block and disruption of protein trafficking

Aktive Filter

Suchergebnisse filtern